Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.

Jung Soo KimMin Seong ChoJong Hyeon NamHyun-Jung KimKyeng-Won ChoiJeong-Seon Ryu

Published in: PloS one (2017)

In comparison to patients without the family history, EGFR activating mutation was common, and it did not affect prognosis in patients with positive family history.

Keyphrases

small cell lung cancer
end stage renal disease
epidermal growth factor receptor
ejection fraction
chronic kidney disease
prognostic factors
signaling pathway
peritoneal dialysis
patient reported outcomes
clinical evaluation